Analysts: CRBU, SOPA, SNDX, TOST, BLFS, CMC, HVT, NWL, HLMN are a Buy
- July 12th, 2023
- 390 views
Caribou Biosciences, Inc. (Nasdaq: CRBU), a company that operates in the field of genome editing and develops CRISPR-based technologies for various applications, was initiated with a Buy rating by Truist, accompanied by a price target of $23.
Despite closing at $7.69 on Tuesday, the assigned price target suggests a potential upside of $15.31 or approximately 199.17% for $CRBU, based on the financial services firm's analysis.
Society Pass Incorporated (Nasdaq: SOPA), an emerging technology company that offers a digital commerce platform, was initiated for coverage by Ascendiant Capital with a Buy rating and a price target of $3.5.
With $SOPA closing at $0.60 on Tuesday, the stated price target indicates a potential upside of $2.90 or approximately 483.33% according to the research firm's perspective.
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a biopharmaceutical company focused on developing therapies for cancer patients, received coverage initiation from Guggenheim with a Buy rating and a price target of $40.
Based on Tuesday's closing price of $20.29, the assigned price target suggests a potential upside of $19.71 or approximately 97.09% for $SNDX, according to the investment and advisory firm's assessment.
Toast, Inc. (NYSE: TOST), a technology company that provides a cloud-based restaurant management platform, was initiated with a Buy rating by Jefferies, accompanied by a price target of $28.
Despite $TOST closing at $23.50 on Tuesday, the stated price target indicates a potential upside of $4.50 or approximately 19.15% based on the investment advisory firm's view.
BioLife Solutions, Inc. (Nasdaq: BLFS), a leading provider of biopreservation tools and services for cell and gene therapies, was initiated for coverage by Craig-Hallum with a Buy rating and a price target of $29.
With $BLFS closing at $22.96 on Tuesday, the assigned price target suggests a potential upside of $6.04 or approximately 26.31% according to the investment banking firm's analysis.
Commercial Metals Company (NYSE: CMC), a global manufacturer, recycler, and distributor of steel and metal products, received coverage initiation from UBS with a Buy rating and a price target of $63.
Based on Tuesday's closing price of $54.41, the stated price target indicates a potential upside of $8.59 or approximately 15.80% for $CMC, based on the investment services firm's perspective.
Haverty Furniture Companies, Inc. (NYSE: HVT), a retailer of residential furniture and accessories, was initiated with a Buy rating by Benchmark, accompanied by a price target of $41.
Despite closing at $32.01 on Tuesday, the assigned price target suggests a potential upside of $8.99 or approximately 28.08% for $HVT, according to the investment firm's analysis.
Newell Brands Inc. (Nasdaq: NWL), a consumer goods company that designs, manufactures, and sells a wide range of products, was initiated for coverage by Canaccord Genuity with a Buy rating and a price target of $13.
With $NWL closing at $9.87 on Tuesday, the stated price target indicates a potential upside of $3.13 or approximately 31.71% based on the financial services firm's view.
Hillman Solutions Corp. (Nasdaq: HLMN), a leading provider of hardware and home improvement solutions, , received coverage initiation from Canaccord Genuity with a Buy rating and announced price target of $12.
Based on Tuesday's closing price of $9.42, the assigned price target suggests a potential upside of $2.58 or approximately 27.37% for $HLMN, according to the investment banking firm's analysis.
The potential upsides mentioned for these companies are derived from evaluations and recommendations provided by brokerage firms or analysts, which represent their perspective on the future performance of each respective company. However, it is crucial for investors to conduct their own research and take into account other factors before making any investment decisions.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025




Member Login